Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Rectal Neoplasms 4Glioblastoma 3Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Radiation Injuries 2Prostatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lung Neoplasms 2Invasive Breast Cancer 2Head and Neck Neoplasms 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Tuberous Sclerosis 1Thyroid Neoplasms 1Stomach Neoplasms 1Stomach Diseases 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Respiratory Aspiration 1Prostate Adenocarcinoma 1Premenopausal Breast Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1

Interventions

camrelizumab 1apatinib 1Tegafur 1Surgical Procedures, Operative 1Oxaliplatin 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Advanced Biliary Tract Carcinoma × Surgical Procedures, Operative × Clear all
NCT05451290 2026-02-12

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

First Affiliated Hospital of Zhejiang University

Phase 2 Active not recruiting
30 enrolled
Gastrointestinal

Advanced Biliary Tract Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡